The biotech sector could see a period of relative stability, according to a time-series analysis of the NASDAQ Biotech Index. In recent years, however, performance of the NBI has had little bearing on the rate of layoffs in the pharma and biotech sectors. A statistical analysis of the relationship between the NBI performance and the…